This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Japan Health Sciences Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Noritoshi Nagaya: Innovator in Mesenchymal Stem Cell Therapy
Introduction
Noritoshi Nagaya is a prominent inventor based in Suita, Japan. He is known for his groundbreaking work in the field of regenerative medicine, particularly involving mesenchymal stem cells. His innovative approach has the potential to revolutionize treatments for heart diseases.
Latest Patents
Nagaya holds a patent for a "Cell sheet containing mesenchymal stem cells." This invention highlights the therapeutic potential of mesenchymal stem cells, which are pluripotent and capable of differentiating into myocardial and vascular endothelial cells. The patent demonstrates that the mesenchymal stem cell sheet can be used to treat severely damaged hearts due to its pluripotency and in situ self-renewal capability. The process involves culturing mesenchymal stem cells derived from adipose tissue to prepare a cell sheet. After inducing myocardial infarction in rats, the cell sheet was transplanted to the heart, where it engrafted to the scarred myocardium and formed a thick layer over four weeks. This innovative approach showed promising results in improving cardiac function and survival rates in rats with myocardial infarcts.
Career Highlights
Throughout his career, Nagaya has made significant contributions to the field of health sciences. He has worked with notable organizations such as the Japan Health Sciences Foundation and the National Cerebral and Cardiovascular Center. His research has focused on the application of stem cell technology in regenerative medicine, particularly for cardiac repair.
Collaborations
Nagaya has collaborated with esteemed colleagues, including Hidezo Mori and Yoshinori Miyahara. These partnerships have further advanced the research and application of mesenchymal stem cells in therapeutic settings.
Conclusion
Noritoshi Nagaya's innovative work in mesenchymal stem cell therapy represents a significant advancement in regenerative medicine. His contributions have the potential to improve treatment outcomes for patients with heart diseases, showcasing the importance of continued research in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile